Knowing01
Knowing01 helps biotech teams reduce risk in early-stage drug discovery by contextualizing multiomics and molecular data to improve target validation and indication selection. The company offers a Biotech SaaS MultiomicsAI platform that links and prepares data from NGS, mass spectrometry, and microarray sources, and supplements software with serviced analyses and strategic partnerships. Core technologies include the proprietary Cellmap, knowledge graphs, machine learning, and AI to establish large-scale biological links and surface actionable insights. Its customers are primarily biotech and pharmaceutical companies seeking to accelerate in silico R&D and strengthen data-backed decision making.
Knowing01
Knowing01 helps biotech teams reduce risk in early-stage drug discovery by contextualizing multiomics and molecular data to improve target validation and indication selection. The company offers a Biotech SaaS MultiomicsAI platform that links and prepares data from NGS, mass spectrometry, and microarray sources, and supplements software with serviced analyses and strategic partnerships. Core technologies include the proprietary Cellmap, knowledge graphs, machine learning, and AI to establish large-scale biological links and surface actionable insights. Its customers are primarily biotech and pharmaceutical companies seeking to accelerate in silico R&D and strengthen data-backed decision making.